Search
Blog: Focus On Regulation | 06 September 2018
On 23 August 2018, the European Medicines Agency (EMA) and the Heads of Medicines Agencies (HMA), the network of the National Competent Authorities in the European Economic Area (EEA), published the work program of their joint task force regarding the availability of authorized medicines for human and veterinary use.
The HMA-EMA task force was created to develop and coordinate actions on the availability of human and veterinary medicinal products authorized in the EU. It establishes links with existing working groups and ensures that any activities related to the availability issues in their field are reflected in their respective work programs.
Click here to read more on HMA-EMA’s work programme on availability of authorised medicines for human and veterinary use includes measures for Brexit.
Partner
London
